Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
2006 Standout
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
2010 StandoutScienceNobel
Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease
2010
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
2006 StandoutScience
Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor
1998
Tumor Necrosis Factor (TNF)-mediated Neuroprotection against Glutamate-induced Excitotoxicity Is Enhanced by N-Methyl-D-aspartate Receptor Activation
2004
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.
2003
Mucormycosis (Zygomycosis) in a Heart-Kidney Transplant Recipient: Recovery after Posaconazole Therapy
2003
EGFR Antagonists in Cancer Treatment
2008 Standout
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
2006 StandoutNature
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Inflammatory processes in Alzheimer's disease
2007
Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam scan study
2002
Apoptosis in the nervous system
2000 StandoutNature
Inflammation and metabolic disorders
2006 StandoutNature
Disease-Specific Induced Pluripotent Stem Cells
2008 Standout
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
1996
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Pathology of Parkinson’s disease
1991
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
2002 StandoutNature
Alzheimer's disease
2011 Standout
The Relationship between Lewy Body Disease, Parkinson's Disease, and Alzheimer's Disease
2003
Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease
2010
Decreased Prefrontal Myo-Inositol in Major Depressive Disorder
2005
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease
2006
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
2011
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
2008 Standout
Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing
2015
Clinical and biochemical correlates of insoluble α-synuclein in dementia with Lewy bodies
2006
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
2008
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
2012 StandoutNature
Decoding ALS: from genes to mechanism
2016 StandoutNature
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Statins for the prevention of dementia
2009
Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau
1998
Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease
2012
Neuronal nicotinic receptors in the human brain
2000
Parkinson's disease
2015 Standout
Neurovascular regulation in the normal brain and in Alzheimer's disease
2004 Standout
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
A distributional code for value in dopamine-based reinforcement learning
2020 StandoutNatureNobel
Vascular cognitive impairment
2003 Standout
Behavioral and Psychological Symptoms of Dementia
2012
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
2005 StandoutNobel
Immunohistochemical and Biochemical Studies Demonstrate a Distinct Profile of α-Synuclein Permutations in Multiple System Atrophy
2000
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury
2003 StandoutNature
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
The role of cerebral ischemia in Alzheimer’s disease
2000
Parkinson's disease and α‐synuclein expression
2011
Combined Antifungal Treatment of Visceral Mucormycosis with Caspofungin and Liposomal Amphotericin B
2002
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
The four ages of Down syndrome
2006
Alzheimer's Disease
2010 Standout
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
2003 Standout
Major Depressive Disorder
2008 Standout
Selective Insolubility of α-Synuclein in Human Lewy Body Diseases Is Recapitulated in a Transgenic Mouse Model
2001
Neuropathologic substrates of Parkinson disease dementia
2012
A Drosophila model of Parkinson's disease
2000 StandoutNature
HumanAPOEIsoform-Dependent Effects on Brain β-Amyloid Levels in PDAPP Transgenic Mice
2009
Cortical α7 Nicotinic Acetylcholine Receptor and β-Amyloid Levels in Early Alzheimer Disease
2009
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts
2011
Genetics of Alzheimer’s Disease
2014
Relationship of Apolipoprotein E and Age at Onset to Parkinson Disease Neuropathology
2006
Glia and alpha-synuclein in neurodegeneration: A complex interaction
2015
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors
2001 StandoutNature
[11C]PIB-amyloid binding and levels of Aβ40 and Aβ42 in postmortem brain tissue from Alzheimer patients
2008
Identification of human brain tumour initiating cells
2004 StandoutNature
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
2013 Standout
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine
1999
Microglia as a source and target of cytokines
2002
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Cell Signaling by Receptor Tyrosine Kinases
2000 Standout
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
1999 StandoutNature
Inflammation and NF-κB in Alzheimer's Disease and Diabetes
2009
Alzheimer Disease as a Vascular Disorder
2002
Zygomycetes in Human Disease
2000 Standout
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
Autocrine Tumor Necrosis Factor Alpha Links Endoplasmic Reticulum Stress to the Membrane Death Receptor Pathway through IRE1α-Mediated NF-κB Activation and Down-Regulation of TRAF2 Expression
2006
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
Exploring the Etiology of Alzheimer Disease Using Molecular Genetics
1997
Blood–Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer’s Disease
2017
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Neuronal nicotinic receptors: from structure to function
2001
Neuroleptic drugs in dementia: benefits and harm
2006
Emerging Targets in Photopharmacology
2016 StandoutNobel
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
Zygomycosis in the 1990s in a Tertiary-Care Cancer Center
2000
Works of Robert Perry being referenced
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.
1997
Pathologies and Pathological Mechanisms for White Matter Hyperintensities in Depression
2002
Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases
1988
The role of TNF and its receptors in Alzheimer's disease
2001
Cutaneous mucormycosis with subsequent visceral dissemination in a child with neutropenia: A case report and review of the pediatric literature
1997
Quantification of Alzheimer pathology in ageing and dementia: age‐related accumulation of amyloid‐β(42) peptide in vascular dementia
2006
Senile dementia of the Lewy body type has an apolipoprotein E ε4 allele frequency intermediate between controls and Alzheimer's disease
1994
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases
2000
The Association between White Matter Lesions on Magnetic Resonance Imaging and Noncognitive Symptoms
2000
Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma
2001
Apolipoprotein E ε2 allele promotes longevity and protects patients with Downʼs syndrome from dementia
1994
Neuropathological Substrates of Dementia and Depression in Vascular Dementia, with a Particular Focus on Cases with Small Infarct Volumes
2000
Lewy body dementia — clinical, pathological and neurochemical interconnections
1997
Mutation screening in exons 3 and 4 of α-synuclein in sporadic Parkinsonʼs and sporadic and familial dementia with Lewy bodies cases
1998
Towards defining the neuropathological substrates of vascular dementia
2004
Anxiety, depression and psychosis in vascular dementia: prevalence and associations
2000
The Rate of Cognitive Decline in Parkinson Disease
2004
Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum
2002
Aspects of Dementia
1997
Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes
2002
Dementia with Lewy bodies
2003
Apolipoprotein E ϵ4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls
1994
Nicotinic receptor distribution in the human thalamus: autoradiographical localization of [3H]nicotine and [125I]α-bungarotoxin binding
1997
ApoE2 Allele, Down's Syndrome, and Dementiaa
1996
Neuropathology of dementia in Parkinson's disease: A prospective, community‐based study
2005
Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia
1999
White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging
1999
Clinical neurochemistry: developments in dementia research based on brain bank material
1998
Accumulation of dipeptide repeat proteins predates that of TDP ‐43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene
2014
Neuroleptic Sensitivity in Parkinson's Disease and Parkinsonian Dementias
2005